Your browser doesn't support javascript.
loading
Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein.
Lapidus, Sarah; Liu, Feimei; Casanovas-Massana, Arnau; Dai, Yile; Huck, John D; Lucas, Carolina; Klein, Jon; Filler, Renata B; Strine, Madison S; Sy, Mouhamad; Deme, Awa B; Badiane, Aida S; Dieye, Baba; Ndiaye, Ibrahima Mbaye; Diedhiou, Younous; Mbaye, Amadou Moctar; Diagne, Cheikh Tidiane; Vigan-Womas, Inés; Mbengue, Alassane; Sadio, Bacary D; Diagne, Moussa M; Moore, Adam J; Mangou, Khadidiatou; Diallo, Fatoumata; Sene, Seynabou D; Pouye, Mariama N; Faye, Rokhaya; Diouf, Babacar; Nery, Nivison; Costa, Federico; Reis, Mitermayer G; Muenker, M Catherine; Hodson, Daniel Z; Mbarga, Yannick; Katz, Ben Z; Andrews, Jason R; Campbell, Melissa; Srivathsan, Ariktha; Kamath, Kathy; Baum-Jones, Elisabeth; Faye, Ousmane; Sall, Amadou Alpha; Vélez, Juan Carlos Quintero; Cappello, Michael; Wilson, Michael; Ben-Mamoun, Choukri; Tedder, Richard; McClure, Myra; Cherepanov, Peter; Somé, Fabrice A.
Affiliation
  • Lapidus S; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Liu F; Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06510, USA.
  • Casanovas-Massana A; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Dai Y; Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06510, USA.
  • Huck JD; Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06510, USA.
  • Lucas C; Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06510, USA.
  • Klein J; Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06510, USA.
  • Filler RB; Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06510, USA.
  • Strine MS; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, 06510, USA.
  • Sy M; Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06510, USA.
  • Deme AB; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, 06510, USA.
  • Badiane AS; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Dieye B; Laboratory of Parasitology and Mycology, Aristide le Dantec Hospital, Cheikh Anta Diop University, Dakar, Senegal.
  • Ndiaye IM; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Diedhiou Y; Laboratory of Parasitology and Mycology, Aristide le Dantec Hospital, Cheikh Anta Diop University, Dakar, Senegal.
  • Mbaye AM; Laboratory of Parasitology and Mycology, Aristide le Dantec Hospital, Cheikh Anta Diop University, Dakar, Senegal.
  • Diagne CT; Laboratory of Parasitology and Mycology, Aristide le Dantec Hospital, Cheikh Anta Diop University, Dakar, Senegal.
  • Vigan-Womas I; Laboratory of Parasitology and Mycology, Aristide le Dantec Hospital, Cheikh Anta Diop University, Dakar, Senegal.
  • Mbengue A; Laboratory of Parasitology and Mycology, Aristide le Dantec Hospital, Cheikh Anta Diop University, Dakar, Senegal.
  • Sadio BD; Laboratory of Parasitology and Mycology, Aristide le Dantec Hospital, Cheikh Anta Diop University, Dakar, Senegal.
  • Diagne MM; DiaTROPIX Rapid Diagnostic Tests Facility, Institut Pasteur de Dakar, Dakar, Senegal.
  • Moore AJ; Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
  • Mangou K; G4-Malaria Experimental Genetic Approaches and Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
  • Diallo F; Pôle Virologie, Institut Pasteur de Dakar, Dakar, Senegal.
  • Sene SD; Pôle Virologie, Institut Pasteur de Dakar, Dakar, Senegal.
  • Pouye MN; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Faye R; G4-Malaria Experimental Genetic Approaches and Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
  • Diouf B; G4-Malaria Experimental Genetic Approaches and Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
  • Nery N; G4-Malaria Experimental Genetic Approaches and Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
  • Costa F; G4-Malaria Experimental Genetic Approaches and Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
  • Reis MG; Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
  • Muenker MC; Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
  • Hodson DZ; Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, BA, Brazil.
  • Mbarga Y; Department of Internal Medicine, Yale Occupational and Environmental Medicine Program, Yale School of Medicine, New Haven, CT, USA.
  • Katz BZ; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Andrews JR; Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, BA, Brazil.
  • Campbell M; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador, BA, Brazil.
  • Srivathsan A; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Kamath K; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Ministério da Saúde, Salvador, BA, Brazil.
  • Baum-Jones E; Faculty of Medicine, Federal University of Bahia, Salvador, Brazil.
  • Faye O; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Sall AA; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Vélez JCQ; Douala Military Hospital, Douala, Cameroon.
  • Cappello M; Division of Infectious Diseases, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, USA.
  • Wilson M; Division of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Ben-Mamoun C; Yale Center for Clinical Investigation, Yale School of Medicine, New Haven, CT, USA.
  • Tedder R; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • McClure M; Serimmune, Inc., Goleta, CA, USA.
  • Cherepanov P; Serimmune, Inc., Goleta, CA, USA.
  • Somé FA; Pôle Virologie, Institut Pasteur de Dakar, Dakar, Senegal.
Sci Rep ; 12(1): 22175, 2022 12 22.
Article in En | MEDLINE | ID: mdl-36550362

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 3_ND / 4_TD Database: MEDLINE Main subject: COVID-19 / Malaria Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 3_ND / 4_TD Database: MEDLINE Main subject: COVID-19 / Malaria Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article